The news was very interesting, and could very well mean that this company has their hands on something amazing.
The announcement says they are preparing to present to FDA to explore path to approval. This likely means further, multi year studies.
The results seem fantastic for science/medicine. As for shareholders, they'd better hope for good results and FDA approval for at least one of the other products in the mean time.
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-79
-
- There are more pages in this discussion • 944 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.49 | $1.44 | $3.472M | 2.379M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12398 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 5440 | 3 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |